FRANKLIN TEMPLETON ETF TR - GENOMIC ADV ETF (HELX)

Historical Portfolio Holders from Q1 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / GENOMIC ADV ETF
Shares, excl. options Q1 2024
94.8 K
Holdings value Q1 2024
$3.11 M
Value change Q1 2024
-$1.5 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
9
Number of buys Q1 2024
3
Number of sells Q1 2024
-6
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
35473P520
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 94.8 K $3.11 M -$1.5 M $32.76 9
2023 Q4 141 K $4.29 M +$3.13 M $30.47 9
2023 Q3 38.7 K $1.1 M -$1.32 M $28.34 7
2023 Q2 82.3 K $2.49 M -$37.7 K $30.23 7
2023 Q1 38.8 K $1.18 M -$122 K $30.38 6
2022 Q4 42.8 K $1.29 M +$61.9 K $30.13 9
2022 Q3 40.7 K $1.21 M +$317 K $29.63 9
2022 Q2 30 K $962 K -$80.1 K $32.04 7
2022 Q1 30.5 K $1.13 M -$4.71 M $36.92 7
2021 Q4 155 K $7.53 M -$6.28 M $48.42 11
2021 Q3 274 K $14.3 M +$10.2 M $52.30 10
2021 Q2 79.6 K $4.12 M -$98.5 K $51.79 9
2021 Q1 81.5 K $3.53 M +$1.39 M $43.35 8
2020 Q4 43.3 K $1.92 M +$761 K $44.29 5
2020 Q3 28.2 K $991 K -$1.29 M $35.10 5
2020 Q2 65 K $2.23 M -$343 K $34.29 1
2020 Q1 75 K $1.68 M +$1.68 M $22.37 1